Global Urology Devices Market Forecast To 2026
LONDON, December 7, 2016 /PRNewswire/ --
Urinary Incontinence, Benign Prostatic Hyperplasia (BPH), Kidney Stone, Prostate Cancer
The global urology devices market is expected to grow at a CAGR of 5.8% from 2020-2026 and CAGR of 6.2% from 2016-2020. The market is expected to grow at a CAGR of 6.0% from 2016 to 2026. The market is estimated at $6,126.4 million in 2016, $7,793.0 million in 2020, and $10,971.3 million in 2026.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new report you find 200-page report you will receive 91 tables and 80 charts- all unavailable elsewhere.
The 200 page report provides clear detailed insight into the global urology devices market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Urology Devices Market forecasts from 2016-2026
• Urology Devices National Market forecasts from 2016-2026, covering:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
- China
- India
- Rest of the World
• Urology Devices submarket forecasts from 2016-2026 covering:
- Urinary Incontinence Devices
- Benign Prostatic Hyperplasia (BPH) Devices
- Prostate Cancer Devices
- Kidney Stone Devices
To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com
• Analysis of the key factors driving and restraining the growth of the urology devices market from 2016-2026
• Assessment of selected leading companies, examining recent performance and outlooks:
- C.R. Bard
- Coloplast
- Endo Pharmaceuticals
- Olympus Corporation
- Teleflex
- Braun
- Boston Scientific Corporation
- Cook Group
- Healthtronics
- Intuitive Surgical Inc
- Lumenis
- Medtronic
- Siemens Healthcare
- Urologix
- Urotech
Visiongain's study is intended for anyone requiring commercial analyses for the Urology Devices Market and leading companies. You find data, trends and predictions.
Buy our report today Global Urology Devices Market Forecast to 2026: Urinary Incontinence, Benign Prostatic Hyperplasia (BPH), Kidney Stone, Prostate Cancer.
To request a report overview of this report please emails Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44 (0) 20 7336 6100
Or click on https://www.visiongain.com/Report/1757/Global-Urology-Devices-Market-Forecast-to-2026
Companies and Organisations Mentioned in This Report
Advanced Urotech
American Medical System (AMS)
Aspen Holdings
B. Braun
Boston Scientific
Business Development Bank of Canada
C.R. Bard
Carolina Lithotripsy
Center for Biologics Evaluation and Research (CBER)
Central Drug Standards Control Organization (CDSCO)
China Food and Drug Administration (CFDA)
Coloplast
Cook Group
Department of Health and Human Services
Distal Access, LLC
EastMed Inc.
Endo Pharmaceuticals Holding, Inc.
European Union (EU)
Food and Drug Administration (FDA)
Gran Plasa
Healthronics
Hill-Rom Holdings, Inc.
Intuitive Surgical
Intuitive Surgical, Inc.
Karl Storz
Kobayashi Pharmaceutical Co., Ltd.
Liberator Medical Holdings, Inc.
Lumenis
Mauna Kea Technologies
Medafor, Inc.
Medical Device Regulatory Authority of India (MDRA)
Medicon, Inc,
Medtronic
Mobile Medical Marketing, LLC
MyoPowers
Nostix, LLC
Novartis
Novation
Olympus Corporation
Par Pharmaceutical Holdings, Inc.
Pharmaceuticals Medical Devices Agency (PMDA)
Rochester Medical, Inc.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Siemens
SonoMotion
Spirus Medical, Inc.
Teleflex Inc.
Terumo Corporation
Therapeutic Goods Administration (TGA)
TransEnterix
Truffle Capital
United Therapies, LLC
Urologix
Urotech
World Bank
World Health Organization
To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com
Share this article